Characteristics of Novel Anticoagulants and Potential Economic ImplicationsByEdith Nutescu, PharmD, FCCPMarch 10th 2011
Cost-Effectiveness of Rivaroxaban After Total Hip or Total Knee ArthroplastyByLouis M. Kwong, MD, FACSMarch 10th 2011
New Oral Anticoagulants and Outpatient Prophylaxis of Venous ThromboembolismByWilliam D. Fisher, MDMarch 10th 2011
Quality Improvement Program: Advancement of Hospital Venous Thromboembolism - Free ZonesByGeno Merli, MD, FACP, FHM, FSVMMarch 10th 2011
Prevalence and Economic Burden of Venous Thromboembolism After Total Hip Arthroplasty or Total Knee ArthroplastyByOnur Baser, PhD, MSMarch 10th 2011
Venous Thromboembolism After Total Hip Arthroplasty and Total Knee Arthroplasty: Current and Future PerspectivesByGeno Merli, MD, FACP, FHM, FSVMMarch 10th 2011
Participating Faculty: Venous Thromboembolism After Total Hip Arthroplasty and Total Knee ArthroplastyByMarch 10th 2011
